ClassID:

94279

C07D215/38 - CPC Classification

Classification description:

Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Nitrogen atoms

Sub-classes:
Recent Application in this class:
#1
20260035348
2026-02-05

PHENYL-N-QUINOLINE DERIVATIVES FOR TREATING A RNA VIRUS INFECTION

#2
20250361210
2025-11-27

3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUND

#3
20250359552
2025-11-27

MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO

#4
20250353816
2025-11-20

QUINOLINES AS MODULATORS OF POLRMT

#5
20250313532
2025-10-09

ALDH2 INHIBITORS AND METHODS OF USE THEREOF

#6
20250304528
2025-10-02

OLIGO-BENZAMIDE ANALOGS AND THEIR USE IN CANCER TREATMENT

#7
20250270445
2025-08-28

COMPOUNDS AND USES THEREOF IN FIELD OF OPTOELECTRONICS

#8
20250134105
2025-05-01

MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO

#9
20250115579
2025-04-10

QUINOLINE cGAS ANTAGONIST COMPOUNDS

#10
20250100971
2025-03-27

IN VITRO OR EX VIVO METHODS FOR SCREENING A QUINOLINE DERIVATIVE

#11
20250084048
2025-03-13

PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF

#12
20250034139
2025-01-30

AMINE COMPOUNDS HAVING ANTI-INFLAMMATORY, ANTIFUNGAL, ANTIPARASITIC, AND ANTICANCER ACTIVITY

#13
20250008960
2025-01-09

MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO

#14
20240425458
2024-12-26

SOLID STATE FORMS OF REPROXALAP

#15
20240425457
2024-12-26

COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING METABOLIC DISEASES AND/OR A CLINICAL CONDITION THEREOF

#16
20240376062
2024-11-14

COMPOUNDS FOR THE TREATMENT OF ALZHEIMER’S DISEASE

#17
20240343716
2024-10-17

COMPOUNDS FOR PREVENTING, INHIBITING, OR TREATING CANCER, AIDS AND/OR PREMATURE AGING

#18
20240327388
2024-10-03

QUINOLINAMINE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN PHARMACEUTICALS

#19
20240327354
2024-10-03

GRAM-NEGATIVE BACTERIA EFFLUX PUMP INHIBITORS

#20
20240308964
2024-09-19

PHENYL-N-QUINOLINE DERIVATIVES FOR TREATING A RNA VIRUS INFECTION

#21
20240245673
2024-07-25

Papain-like protease (PLpro) inhibitors

#22
20240217916
2024-07-04

ORGANIC COMPOUND AND USE THEREOF

#23
20240199636
2024-06-20

Inhibitors of RAD52 Recombination Protein and Methods Using Same

#24
20240182422
2024-06-06

PREPARATION METHOD OF QUINOLINE DERIVATIVE COMPOUNDS

#25
20240180916
2024-06-06

Theramutein modultors

#26
20240174614
2024-05-30

COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE

#27
20240166624
2024-05-23

PPARG INVERSE AGONISTS AND USES THEREOF

#28
20240132451
2024-04-25

Deuterated compounds and uses thereof

#29
20240116885
2024-04-11

BENZOTHIAZOLE AND QUINOLINE DERIVATIVES AND THEIR USE

#30
20240092760
2024-03-21

Quinoline cGAS antagonist compounds

#31
20240025856
2024-01-25

1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES AS INHIBITORS OF THE YAP/TAZ-TEAD ACTIVATION FOR TREATING CANCER

#32
20230373974
2023-11-23

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

#33
20230295094
2023-09-21

NITROXOLINE DERIVATIVE, PREPARATION METHOD THEREFOR, AND USE THEREOF

#34
20230286904
2023-09-14

INHIBITORS OF YAP/TAZ-TEAD ONCOPROTEINS, SYNTHESIS AND USE THEREOF

#35
20230250067
2023-08-10

Caspase inhibitors and methods of use thereof

#36
20230242496
2023-08-03

SOX11 INHIBITORS FOR TREATING MANTLE CELL LYMPHOMA

#37
20230227410
2023-07-20

TETRAHYDROQUINOLINE DERIVATIVES AND A PROCESS OF PREPARATION THEREOF

#38
20230227409
2023-07-20

QUINOLINONE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS

#39
20230183179
2023-06-15

NOVEL CELL METABOLISM MODULATING COMPOUNDS AND USES THEREOF

#40
20230180761
2023-06-15

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#41
20230174491
2023-06-08

Deuterated compounds and uses thereof

#42
20230159504
2023-05-25

7- OR 8-HYDROXY-ISOQUINOLINE AND 7- OR 8-HYDROXY-QUINOLINE DERIVATIVES AS ALPHA-1-ANTITRYPSIN MODULATORS FOR TREATING ALPHA-1-ANTITRYPSIN DEFICIENCY (AATD)

#43
20230148316
2023-05-11

ANTHELMINTIC COMPOUNDS COMPRISING A QUINOLINE STRUCTURE

#44
20230131025
2023-04-27

QUINOLYL PHOSPHINE OXIDE COMPOUND, AND COMPOSITION AND APPLICATION THEREOF

#45
20230118116
2023-04-20

ARYLAMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE

#46
20230117592
2023-04-20

LIPOXYGENASE INHIBITORS

#47
20230108906
2023-04-06

SUBSTITUTED BICYCLIC AND TRICYCLIC UREAS AND AMIDES, ANALOGUES THEREOF, AND METHODS USING SAME

#48
20230081291
2023-03-16

Quinoline cGAS antagonist compounds

#49
20230067676
2023-03-02

CO-CRYSTALS AND SALTS OF 8-CHLORO-N-(4-(TRIFLUOROMETHOXY)PHENYL)QUINOLIN-2-AMINE

#50
20230042881
2023-02-09

MODULATORS OF INTEGRATED STRESS RESPONSE PATHWAY

#51
20230041335
2023-02-09

COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE

#52
20220411377
2022-12-29

SELECTIVE NEURONAL NITRIC OXIDE SYNTHASE INHIBITORS

#53
20220402883
2022-12-22

COMPOUNDS AND METHODS FOR MODULATING RNA FUNCTION

#54
20220396581
2022-12-15

COMPOUNDS FOR THE TREATMENT OF PARAMYXOVIRUS VIRAL INFECTIONS

#55
20220396553
2022-12-15

NOVEL HYDRAZONE DERIVATIVE IN WHICH TERMINAL AMINE GROUP IS SUBSTITUTED WITH ARYL GROUP OR HETEROARYL GROUP, AND USE THEREOF

#56
20220388980
2022-12-08

QUINOLINE INHIBITORS OF RAD52 AND METHODS OF USE

#57
20220370469
2022-11-24

Theramutein modulators

#58
20220363665
2022-11-17

QUINOLINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE

#59
20220362257
2022-11-17

Theramutein modulators

#60
20220315535
2022-10-06

In vitro or ex vivo methods for screening a quinoline derivative

#61
20220298115
2022-09-22

SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2)

#62
20220227700
2022-07-21

HDAC3 CATALYTIC INHIBITOR DEVELOPMENT AND USES THEREOF

#63
20220177515
2022-06-09

METHOD FOR MODIFYING AMINO GROUP IN MOLECULE WITH THE ZOLINIUM AND USE THEREOF

#64
20220162167
2022-05-26

SUBSTITUTED BICYCLIC AND TETRACYCLIC QUINONES AND USE THEREOF AS ANTI-CANCER AGENTS

#65
20220144775
2022-05-12

HYDRAZIDE COMPOUND AND KINASE INHIBITOR

#66
20220127253
2022-04-28

COMPOUNDS FOR PREVENTING, INHIBITING, OR TREATING CANCER, AIDS AND/OR PREMATURE AGING

#67
20220089542
2022-03-24

Process for preparation of aldehyde scavenger and intermediates

#68
20220071985
2022-03-10

QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OR PREVENTION OF CANCER

#69
20220017514
2022-01-20

Heterocyclic compound

#70
20220017454
2022-01-20

Oligo-benzamide analogs and their use in cancer treatment

#71
20220015364
2022-01-20

Preparation of mammalian oocyte for fertilization via a soluble human PH20 hyaluronidase polypeptide

#72
20220009893
2022-01-13

Solid state forms of Reproxalap

#73
20220002251
2022-01-06

Human TLR8-selective agonists

#74
20210403432
2021-12-30

COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING METABOLIC DISEASES AND/OR A CLINICAL CONDITION THEREOF

#75
20210393612
2021-12-23

Polymorphic compounds and uses thereof

#76
20210380551
2021-12-09

α,β-unsaturated amide compound

#77
20210353602
2021-11-18

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

#78
20210347735
2021-11-11

Deuterated compounds and uses thereof

#79
20210346358
2021-11-11

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

#80
20210309611
2021-10-07

Phenyl-n-quinoline derivatives for treating a RNA virus infection

#81
20210269403
2021-09-02

Microbiocidal quinoline carboxamide derivatives

#82
20210269402
2021-09-02

Compositions and methods of treating retinal disease

#83
20210253530
2021-08-19

C-met modulators and methods of use

#84
20210220408
2021-07-22

ARYL HYDROCARBON RECEPTOR ANTAGONISTS AND METHODS OF USE

#85
20210198277
2021-07-01

AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS

#86
20210163516
2021-06-03

Complexes

#87
20210163476
2021-06-03

Imidazoquinolyl compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

#88
20210155612
2021-05-27

α,β-unsaturated amide compound

#89
20210155594
2021-05-27

HETEROCYCLIC DERIVATIVES AND USE THEREOF

#90
20210139435
2021-05-13

PROSTAGLANDIN ANALOGS AND USES THEREOF

#91
20210107876
2021-04-15

Histone methyltransferase inhibitors

#92
20210087145
2021-03-25

Use of quinoline derivatives for the treatment of inflammatory diseases

#93
20210047273
2021-02-18

Use of quinoline derivatives for the treatment of inflammatory diseases

#94
20210040108
2021-02-11

Inhibitors of RAD52 Recombination Protein and Methods Using Same

#95
20210017153
2021-01-21

AHR inhibitors and uses thereof

#96
20210015825
2021-01-21

Theramutein modulators

#97
20210008077
2021-01-14

Theramutein modulators

#98
20200385344
2020-12-10

Compounds and pharmaceutical composition associated with ubiquitination-proteasome system

#99
20200339549
2020-10-29

CXCR2 antagonist

#100
20200331860
2020-10-22

C-Met Modulators and Methods of Use

#101
20200308135
2020-10-01

LXR inverse agonists for treatment of cancer

#102
20200308117
2020-10-01

Use for dyeing keratin fibers of a compound of azomethine type bearing a quinoline-derived unit

#103
20200283396
2020-09-10

Caspase inhibitors and methods of use thereof

#104
20200277277
2020-09-03

Aromatic compound, pharmaceutical composition and use thereof

#105
20200267978
2020-08-27

MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES

#106
20200260728
2020-08-20

Microbiocidal quinoline (thio)carboxamide derivatives

#107
20200248069
2020-08-06

FLUORESCENT PROBE, PREPARATION METHOD THEREFOR AND USE THEREOF

#108
20200245621
2020-08-06

Microbiocidal quinoline (thio)carboxamide derivatives

#109
20200239429
2020-07-30

Aromatic compound, pharmaceutical composition and use thereof

#110
20200199075
2020-06-25

Deuterated compounds and uses thereof

#111
20200196607
2020-06-25

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#112
20200190034
2020-06-18

Substituted 1,2,3,4-tetrahydroquinolines as inhibitors of repair enzyme 8-oxoguanine deoxyribonucleic acid glycosylase activity

#113
20200181090
2020-06-11

6-aminoisoquinoline compounds

#114
20200172525
2020-06-04

Compounds and pharmaceutical compositions containing at least one of the compounds

#115
20200087332
2020-03-19

Syntheses of allyl phosphine complexes of palladium

#116
20200062713
2020-02-27

Process for preparing quinolin-2-yl-phenylamine derivatives and their salts

#117
20200062712
2020-02-27

ALDEHYDE TRAPPING COMPOUNDS AND USES THEREOF

#118
20200046718
2020-02-13

Theramutein modulators

#119
20200039923
2020-02-06

Heat shock protein 90 inhibitors

#120
20200022972
2020-01-23

Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof

#121
20200022368
2020-01-23

Microbiocidal quinoline (thio)carboxamide derivatives

#122
20200010422
2020-01-09

Metal chelators for imaging, therapeutics, and bioanalysis

#123
20190382347
2019-12-19

Use of quinoline derivatives for the treatment of inflammatory diseases

#124
20190375761
2019-12-12

Inhibitors of RAD52 recombination protein and methods using same

#125
20190375715
2019-12-12

Quinolinone or quinazolinone comprising antibiofilm compositions, compounds and methods and uses relating thereto

#126
20190367527
2019-12-05

Substituted phenethylamine derivatives

#127
20190359573
2019-11-28

Inhibitors of bromodomain-containing protein 4 (BRD4)

#128
20190345162
2019-11-14

Methods and compositions for inhibition of bromodomain-containing proteins

#129
20190322656
2019-10-24

Compound, and production method thereof, and methods of treatment using the compound

#130
20190284141
2019-09-19

Histone deacetylase 6 inhibitors and use thereof

#131
20190241589
2019-08-08

Allyl phosphine complexes of palladium and their use in catalysis

#132
20190241504
2019-08-08

Myocyte enhancer factor 2 (MEF2) modulators

#133
20190233444
2019-08-01

Trisubstitutedsilylphenoxyheterocycles and analogues

#134
20190210971
2019-07-11

Compositions and methods of treating retinal disease

#135
20190209536
2019-07-11

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

#136
20190194193
2019-06-27

Aminoquinazoline compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

#137
20190175567
2019-06-13

Compounds and methods for kinase modulation, and indications therefor

#138
20190151306
2019-05-23

MDR-reversing 8-hydroxy-quinoline derivatives

#139
20190144450
2019-05-16

Modulators of ATP-binding cassette transporters

#140
20190144383
2019-05-16

Compounds and pharmaceutical composition associated with ubiquitination-proteasome system

#141
20190135759
2019-05-09

METHOD OF TREATING PAIN

#142
20190119212
2019-04-25

Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates

#143
20190090488
2019-03-28

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#144
20190077761
2019-03-14

Nitrogen-containing heterocyclic compound

#145
20190077760
2019-03-14

Process for preparing quinolin-2-yl-phenylamine derivatives and their salts

#146
20190070320
2019-03-07

Organomedicinals for imaging and treatment of neurodegenerative disorders

#147
20190055218
2019-02-21

AHR inhibitors and uses thereof

#148
20190046520
2019-02-14

Quinolinone lysyl oxidase-like 2 inhibitors and uses thereof

#149
20190023659
2019-01-24

Process for the preparation of polyfluoroalkylated quinolines

#150
20190010136
2019-01-10

α,β-unsaturated amide compound

#151
20190010126
2019-01-10

Sulfonamide compounds and uses as TNAP inhibitors

#152
20190000084
2019-01-03

High stress resistant plant growth regulator and preparation method and use thereof

#153
20180360039
2018-12-20

Small molecule compound for enhancing plant stress resistance

#154
20180354905
2018-12-13

Deuterated compounds and uses thereof

#155
20180339981
2018-11-29

Compounds for preventing, inhibiting, or treating cancer, aids and/or premature aging

#156
20180312470
2018-11-01

Derivatives of halo quinabactin

#157
20180309058
2018-10-25

Pyrene derivative, organic light-emitting medium, and organic electroluminescent element containing pyrene derivative or organic light- emitting medium

#158
20180298000
2018-10-18

AMINOQUINOLINE COMPOUNDS HAVING ANTICANCER ACTIVITY

#159
20180265475
2018-09-20

Halogenated quinoline derivatives as antimicrobial agents

#160
20180265474
2018-09-20

Polymorphic compounds and uses thereof

#161
20180258045
2018-09-13

Human TLR8-selective agonists

#162
20180230101
2018-08-16

PROCESS FOR THE PREPARATION OF 5-AMINO-QUINOLIN-2(1H)-ONES AND THEIR TAUTOMER FORMS 5-AMINO-QUINOLIN-2-OLS

#163
20180230092
2018-08-16

NOVEL ANTIVIRAL AGENTS AGAINST HBV INFECTION

#164
20180207628
2018-07-26

Oxalic amide ligands, and uses thereof in copper-catalyzed coupling reaction of aryl halides

#165
20180201583
2018-07-19

Quinolinone or quinazolinone comprising antibiofilm compositions, compounds and methods and uses relating thereto

#166
20180194733
2018-07-12

Compositions and methods of treating retinal disease

#167
20180186746
2018-07-05

6-aminoisoquinoline compounds

#168
20180186745
2018-07-05

Histone methyltransferase inhibitors

#169
20180170862
2018-06-21

Protein tyrosine phosphatases or SHP2 inhibitors and uses thereof

#170
20180170861
2018-06-21

Small molecule inhibitors of protein tyrosine phosphatases and uses thereof

#171
20180148437
2018-05-31

Novel Ezrin Inhibitors and Methods of Making and Using

#172
20180134727
2018-05-17

Inhibitors of RAD52 recombination protein and methods using same

#173
20180134715
2018-05-17

Methods and compositions for inhibition of bromodomain-containing proteins

#174
20180118688
2018-05-03

Small molecule compounds targeting PBX1 transcriptional complex

#175
20180105485
2018-04-19

Cyclic vinylogous amides as bromodomain inhibitors

#176
20180086697
2018-03-29

Inhibitors of human immunodeficiency virus replication

#177
20180057479
2018-03-01

Inhibitors of BCR-ABL mutants and use thereof

#178
20180057444
2018-03-01

Amination and hydroxylation of arylmetal compounds

#179
20180050989
2018-02-22

ALDEHYDE TRAPPING COMPOUNDS AND USES THEREOF

#180
20180042935
2018-02-15

Theramutein modulators

#181
20180009759
2018-01-11

Quinolines and process for the preparation thereof

#182
20180007911
2018-01-11

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#183
20180000087
2018-01-04

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#184
20170355712
2017-12-14

AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS

#185
20170355678
2017-12-14

C-met modulators and methods of use

#186
20170339961
2017-11-30

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#187
20170320829
2017-11-09

Compositions and methods of treating retinal disease

#188
20170319559
2017-11-09

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

#189
20170291875
2017-10-12

QUINOLONES AS INHIBITORS OF CLASS IV BROMODOMAIN PROTEINS

#190
20170283429
2017-10-05

Compounds for the treatment of paramyxovirus viral infections

#191
20170239226
2017-08-24

N-substituted-5-substituted phthalamic acids as sortilin inhibitors

#192
20170226131
2017-08-10

Inhibitors of PI3K-delta and methods of their use and manufacture

#193
20170226095
2017-08-10

Compounds for preventing, inhibiting, or treating cancer, AIDS and/or premature aging

#194
20170217897
2017-08-03

Quinolone derivatives as antibacterials

#195
20170204094
2017-07-20

Selective HDAC3 inhibitors

#196
20170204063
2017-07-20

Quinoline derivatives for the treatment of inflammatory diseases

#197
20170190711
2017-07-06

Urea and amide derivatives of aminoalkylpiperazines and use thereof

#198
20170174710
2017-06-22

Compounds that are S1P modulating agents and/or ATX modulating agents

#199
20170166541
2017-06-15

THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE

#200
20170157110
2017-06-08

METHODS FOR INDUCING INSULIN PRODUCTION AND USES THEREOF

#201
20170121357
2017-05-04

Complexes

#202
20170120231
2017-05-04

Complexes

#203
20170073343
2017-03-16

Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine derivatives as LRRK2 inhibitors

#204
20170056382
2017-03-02

Compounds and methods for kinase modulation, and indications therefor

#205
20170022165
2017-01-26

PQSR modulators

#206
20170000781
2017-01-05

Quinolines as FGFR kinase modulators

#207
20160368877
2016-12-22

2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition

#208
20160355479
2016-12-08

Sulfonamide compounds and uses as TNAP inhibitors

#209
20160347715
2016-12-01

Toll-like receptor 8 agonists

#210
20160347708
2016-12-01

Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides

#211
20160332971
2016-11-17

ARYLQUINOLINE, ARYLQUINOLONE AND ARYLTHIOQUINOLONE DERIVATIVES AND USE THEREOF TO TREAT CANCER

#212
20160326143
2016-11-10

Compounds and uses

#213
20160304522
2016-10-20

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#214
20160302418
2016-10-20

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#215
20160302417
2016-10-20

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

#216
20160297835
2016-10-13

Use of small molecule inhibitors targeting the interaction between RAC GTPase and p67

#217
20160280922
2016-09-29

Disperse dyes, their preparation and their use

#218
20160280656
2016-09-29

6-aminoisoquinoline compounds

#219
20160280652
2016-09-29

Arylquinoline and analog compounds and use thereof to treat cancer

#220
20160271278
2016-09-22

Tau imaging probe

#221
20160268515
2016-09-15

Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative

#222
20160200717
2016-07-14

Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use

#223
20160200666
2016-07-14

Cyclic vinylogous amides as bromodomain inhibitors

#224
20160194690
2016-07-07

Fluorophore chelated lanthanide luminescent probes with improved quantum efficiency

#225
20160193214
2016-07-07

Small molecules to enhance P53 activity

#226
20160185726
2016-06-30

Anthelmintic compounds and compositions and method of using thereof

#227
20160185725
2016-06-30

c-Met Modulators and Method of Use

#228
20160168146
2016-06-16

Compounds and methods for kinase modulation, and indications therefor

#229
20160168098
2016-06-16

Compositions and methods of treating retinal disease

#230
20160145363
2016-05-26

Polymerizable compound, polymerizable composition, polymer, and optically anisotropic material

#231
20160108035
2016-04-21

Cycloalkyl acid derivative, preparation method thereof, and pharmaceutical application thereof

#232
20160096806
2016-04-07

2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition

#233
20160031819
2016-02-04

Base addition salts of nitroxoline and uses thereof

#234
20160024096
2016-01-28

Methods and compositions for inhibition of bromodomain-containing proteins

#235
20160024067
2016-01-28

Fluorescent compounds and uses thereof

#236
20160024004
2016-01-28

Antiviral agents against HBV infection

#237
20160008494
2016-01-14

Tau imaging probe

#238
20150368231
2015-12-24

N-substituted-5-substituted phthalamic acids as sortilin inhibitors

#239
20150364705
2015-12-17

Amine-based compound and organic light-emitting device including the same

#240
20150361077
2015-12-17

Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity

#241
20150353487
2015-12-10

PROCESS FOR THE PREPARATION OF ASYMMETRICAL BIS(THIOSEMICARBAZONES)

#242
20150344432
2015-12-03

Peri-carbinols

#243
20150307478
2015-10-29

Compounds useful for treating AIDS

#244
20150299189
2015-10-22

Amine derivative or salt thereof

#245
20150299130
2015-10-22

Selective HDAC3 inhibitors

#246
20150299129
2015-10-22

Compounds for treating cancer

#247
20150299128
2015-10-22

Quinolyl hydrazones for the treatment of tuberculosis and related diseases

#248
20150284366
2015-10-08

ROR modulators and their uses

#249
20150280139
2015-10-01

Fluoranthene derivative, light-emitting device material containing same, and light-emitting device

#250
20150218143
2015-08-06

Sulfonamide compounds having TRPM8 antagonistic activity

#251
20150216866
2015-08-06

Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors

#252
20150210727
2015-07-30

Compounds and methods for treating mammalian gastrointestinal microbial infections

#253
20150210644
2015-07-30

2-aminoquinoline-based compounds for potent and selective neuronal nitric oxide synthase inhibition

#254
20150209345
2015-07-30

Compositions and methods of treating retinal disease

#255
20150209333
2015-07-30

Compositions and methods of treating retinal disease

#256
20150203515
2015-07-23

Compounds that are S1P modulating agents and/or ATX modulating agents

#257
20150175542
2015-06-25

THIOLACTAMS AND USES THEREOF

#258
20150133491
2015-05-14

Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity

#259
20150133441
2015-05-14

Theramutein modulators

#260
20150126493
2015-05-07

Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease

#261
20150119419
2015-04-30

6-aminoisoquinoline compounds

#262
20150099882
2015-04-09

Quinolinyl glucagon receptor modulators

#263
20150099781
2015-04-09

Compounds and methods for treating mammalian gastrointestinal microbial infections

#264
20150094334
2015-04-02

8-hydroxy quinoline derivatives

#265
20150080472
2015-03-19

Treatment of friedreich's ataxia using histone deacetylase inhibitors

#266
20150080365
2015-03-19

Heteroaryl compounds with cyclic bridging unit

#267
20150057279
2015-02-26

Heteroaryl compounds with A-cyclic bridging unit

#268
20150051245
2015-02-19

Kinase protein binding inhibitors

#269
20150038714
2015-02-05

Process for synthesis of chiral 3-substituted tetrahydroquinoline derivatives

#270
20150038531
2015-02-05

Use of a novel aminopyridine derivative to prevent or treat cancer

#271
20150025108
2015-01-22

8-hydroxy quinoline derivatives

#272
20150025067
2015-01-22

Use of small molecule inhibitors targeting the interaction between Rac GTPase and p67 (phox)

#273
20150011551
2015-01-08

Sulfonamide compounds and uses as TNAP inhibitors

#274
20150000691
2015-01-01

Coupler with 7-amino-1,2,3,4-tetrahydroquinoline structure, dyeing composition comprising same, processes and uses

#275
20140352713
2014-12-04

Coupler with cationic 7-amino-1,2,3,4-tetrahydroquinoline structure, dyeing composition comprising same, processes and uses

#276
20140350262
2014-11-27

Reactivators of organophosphorous inhibited acetylcholinesterase

#277
20140343315
2014-11-20

Modulators of ATP-binding cassette transporters

#278
20140336378
2014-11-13

Benzamide derivative and use thereof

#279
20140329856
2014-11-06

Method of treating pain

#280
20140315947
2014-10-23

Pharmaceutical composition with enhanced efficacy for inhibiting angiogenesis

#281
20140309257
2014-10-16

TOPOISOMERASE INHIBITORS AND METHODS OF MAKING AND USE AS THERAPEUTIC AGENTS

#282
20140296236
2014-10-02

Quinolines as FGFR kinase modulators

#283
20140291646
2014-10-02

Pyrene-based compound and organic light-emitting diode including the same

#284
20140288120
2014-09-25

Compounds useful for treating aids

#285
20140243345
2014-08-28

Selective HDAC3 inhibitors

#286
20140243337
2014-08-28

Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors

#287
20140235857
2014-08-21

Intermediate for manufacture of polymerizable compound and process for manufacture thereof

#288
20140235702
2014-08-21

Small molecule inhibitors of Mcl-1 and the uses of thereof

#289
20140225070
2014-08-14

Compound and organic light-emitting diode including the same

#290
20140221411
2014-08-07

2-hydroxyarylamide derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating cancer containing same as active ingredient

#291
20140221371
2014-08-07

HETEROCYCLIC COMPOUNDS AND THEIR USE AS BINDING PARTNERS FOR 5-HT5 RECEPTORS

#292
20140219989
2014-08-07

Factor IXa inhibitors

#293
20140219960
2014-08-07

Composition for treating hepatitis C virus, regulating phosphorylation of replicase

#294
20140213785
2014-07-31

Process for preparing aromatic and heteroaromatic amines

#295
20140142266
2014-05-22

Polymerizable compound, polymerizable composition, polymer, and optically anisotropic body

#296
20140142114
2014-05-22

Anthelmintic compounds and compositions and method of using thereof

#297
20140135338
2014-05-15

Quinolinyl glucagon receptor modulators

#298
20140135325
2014-05-15

Ezrin inhibitors and methods of making and using

#299
20140134235
2014-05-15

Benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors

#300
20140128428
2014-05-08

Cold menthol receptor antagonists